Royal Bank of Canada »

Bioaffinity Technologies shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Bioaffinity Technologies (BIAF) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Bioaffinity Technologies

Tip: Access up to 7 years of quarterly data

All positions including Bioaffinity Technologies held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioaffinity Technologies by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $999 931 1.07

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Bioaffinity Technologies

Sabby Management
BlackRock
Vanguard Capital Management
Geode Capital Management
J. Safra Sarasin Holding
Vanguard Fiduciary Trust
Susquehanna International
Jane Street
Hrt Financial
Northern Trust
State Street Corporation
Virtu Financial
Parrish Capital
Hanson McClain Advisors
Tower Research Capital

View all funds holding Bioaffinity Technologies